Martin D Johnson

Title: Martin D Johnson: Innovator in Peptide Synthesis Technology

Introduction

Martin D Johnson is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of peptide synthesis, particularly through his innovative patent that enhances the efficiency of manufacturing peptides. His work is recognized for its potential impact on various applications in biochemistry and pharmaceuticals.

Latest Patents

Martin D Johnson holds a patent for a device and method known as the "Three resin reactors in series peptide synthesizer." This Solid Phase Peptide Synthesis (SPPS) device comprises at least two reactors, each containing a quantity of SPPS resin. The reactors are arranged in series, allowing for a streamlined process of de-protecting the protected N-group and coupling amino acids to the de-protected N-group. The system reduces the overall solvent required and utilizes online LCMS to monitor the reactions occurring within the solid phase resin particles.

Career Highlights

Martin is currently employed at Eli Lilly and Company, where he continues to develop and refine his innovative technologies. His work at Eli Lilly has positioned him as a key player in advancing peptide synthesis methods, contributing to the company's reputation for excellence in pharmaceutical research and development.

Collaborations

Throughout his career, Martin has collaborated with esteemed colleagues, including Michael E Kopach and Mark Richard Berglund. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of peptide synthesis.

Conclusion

Martin D Johnson's contributions to peptide synthesis technology exemplify the spirit of innovation in the scientific community. His patented device not only enhances the efficiency of peptide manufacturing but also showcases the importance of collaboration in advancing scientific research.